In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

New and returning investors put $33mm into Still River Systems' Series D round

Executive Summary

Still River Systems (radiotherapy) raised $33mm through what appears to be the company's Series D round. New investor Venrock and returning backer Caxton Health & Life Sciences co-led, and were joined by existing buyer CHL Medical Partners. Venrock and CHL Medical have taken seats on the company's board.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies